Medi Caps Ltd-$

Medi Caps Ltd-$

$MEDICAPQPharmaceuticalsBSE

Medi Caps Ltd-$ (MEDICAPQ) last traded at ₹27.6, a market capitalisation of ₹34.4 crore. Over the past 52 weeks the stock has ranged between ₹20.3 and ₹44.7. Medi Caps Ltd-$ last reported results for the quarter ended Jun 2026, with sales of ₹2.79 crore and net profit of ₹-2.23 crore. The next scheduled event is an other on 1 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Medi Caps Ltd-$ share price and key metrics

Current price
₹27.6
Market cap
₹34.4 cr
Book value
₹89.5
ROE
-2.61%
ROCE
-2.59%
Dividend yield
0.00%
52w high / low
44.7/20.3

Metrics as of 25 Aug 2026. Not real time.

Medi Caps Ltd-$ quarterly results

In the quarter ended Jun 2026, sales were ₹2.79 cr, up 3.7% from ₹2.69 cr a year earlier. Net profit was ₹-2.23 cr, up 36.1% year on year.

Medi Caps Ltd-$ consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales8.294.026.972.692.024.33.452.79
Expenses7.845.87.26.074.935.365.514.62
Operating profit0.45-1.78-0.23-3.38-2.91-1.06-2.06-1.83
OPM %5.43%-44.28%-3.30%-125.65%-144.06%-24.65%-59.71%-65.59%
Other income0.290.162.140.331.530.765.590.05
Interest000.020.010000
Depreciation0.430.430.440.440.440.440.50.45
Profit before tax0.31-2.051.45-3.5-1.82-0.743.03-2.23
Tax %0.00%0.00%-18.62%0.00%0.00%4.05%-0.33%0.00%
Net profit0.31-2.051.72-3.49-1.82-0.773.04-2.23
EPS (₹)0.25-1.641.38-2.80-1.46-0.622.44-1.79

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Medi Caps Ltd-$ annual results

Medi Caps Ltd-$ annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales57.4269.8749.3727.3525.4812.4512.56
Operating profit10.9710.075.190-1.8-9.42-7.86
OPM %19.10%14.41%10.51%0.00%-7.06%-75.66%-62.58%
Net profit11.1310.081.76-2.24-0.57-3.04-1.78
EPS (₹)8.938.081.41-1.80-0.46-2.44-1.43

TTM is the trailing twelve months to the most recent quarter.

Medi Caps Ltd-$ growth and returns

Compounded Sales Growth
10 Years
-12%
5 Years
-26%
3 Years
-37%
TTM
-43%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
%
TTM
49%
Stock Price CAGR
10 Years
3%
5 Years
-11%
3 Years
-12%
1 Year
-35%
Return on Equity
10 Years
1%
5 Years
1%
3 Years
-2%
Last Year
-3%

Medi Caps Ltd-$ shareholding pattern

Promoters held 51.44% at Jun 2026, up from 50.76% at Jun 2025. DIIs 0.02%.

Medi Caps Ltd-$ shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters50.42%50.61%50.76%50.76%50.76%50.76%51.36%51.44%
DIIs0.03%0.03%0.03%0.03%0.03%0.02%0.02%0.02%
Public49.54%49.35%49.21%49.21%49.19%49.21%48.61%48.54%
No. of shareholders11,25511,17611,03310,85110,69210,49310,34910,209

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Upcoming Medi Caps Ltd-$ events

The next scheduled event is an other on 1 Sept 2026.

  • OtherRe-appointment of Chairman/MD and appointment of new CFO and Whole Time Director
  • AGMConvening of 43rd Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Medi Caps Ltd-$ corporate filings

  • Information under Regulation 44 of SEBI (LODR) Regulation, 2015 and Section 108 of Companies Act, 2013 regarding E-Voting through electronic mode for the 43rd Annual General Meeting to ....AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Medi-Caps Limited has issued a formal notification regarding its 43rd Annual General…

    Read the full analysis
  • Intimation for dispatch of letter to those shareholders whose email addresses are not registered with company/registrar & transfer agent/Depository Participants.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Medi Caps Ltd has initiated the process of dispatching physical letters to shareholders…

    Read the full analysis
  • Submission of 43rd Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015Otherslow impact
    Filing PDF

    Cruxal's analysis: Medi Caps Ltd has filed its 43rd Annual Report for the financial year 2025-26 in…

    Read the full analysis
  • Submission of Notice of 43rd Annual General Meeting scheduled to be held on 22nd September, 2026 at 12:30 PM (IST) through Video Conference (VC)/Other audio Visual means (OAVM).AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Medi-Caps Limited has scheduled its 43rd Annual General Meeting for September 22, 2026…

    Read the full analysis
  • Submission of Newspaper publication regarding information of 43rd Annual General Meeting before dispatch of notice and Annual Report 2025-26Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Medi Caps Ltd has submitted a newspaper publication regarding the information of its 43rd…

    Read the full analysis
  • Pursuant to the requirement of regulation 30 (5) of SEBI (LODR), Regulation 2015, authorization to the person for the purpose of demining the materiality of event or information and for ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Medi Caps Ltd has filed a disclosure regarding the authorization of specific personnel…

    Read the full analysis
  • Standalone and consolidated un audited results for the quarter ended 30.06.2026 approved by the Board in their 02/2026-27 board meeting held on 06.08.2026. An extract of the same published ....Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Medi-Caps Limited has reported a standalone net loss of 2.23 crore for the quarter ended…

    Read the full analysis
  • Resignation of Mr. Akshit Garg, From the post of General Manager & Senior management personnel and Mrs. Saloni Garg, from the post of Senior Manager & senior management personnel w.e.f. 06.08.2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Medi-Caps Limited has disclosed an internal leadership transition where Mrs. Saloni Garg…

    Read the full analysis
  • Appointment of Mr. Akshit Garg as Chief Financial officer (CFO) of the Company w.e.f. 07.08.2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Medi-Caps Limited has announced the re-appointment of Mr. Alok K. Garg as Chairman cum…

    Read the full analysis
  • Outcome of the meeting of the board of directors held on 06.08.2026Board Meetingmedium impact
    Filing PDF

    Cruxal's analysis: Medi-Caps Limited reported a consolidated net loss of 2.23 crore for the quarter ended 30…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Medi Caps Ltd-$

Cruxal reads every Medi Caps Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Medi Caps Ltd-$ (MEDICAPQ) Results, Financials & Share Price | Cruxal